| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |